Last updated: 16 June 2019 at 6:05pm EST

Andrew A Wolff Net Worth




The estimated Net Worth of Andrew A Wolff is at least 2.31 百万$ dollars as of 11 March 2015. Andrew Wolff owns over 21,875 units of Cytokinetics Inc stock worth over 2,314,046$ and over the last 20 years Andrew sold CYTK stock worth over 0$.

Andrew Wolff CYTK stock SEC Form 4 insiders trading

Andrew has made over 1 trades of the Cytokinetics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Andrew exercised 21,875 units of CYTK stock worth 137,813$ on 11 March 2015.

The largest trade Andrew's ever made was exercising 21,875 units of Cytokinetics Inc stock on 11 March 2015 worth over 137,813$. On average, Andrew trades about 1,287 units every 0 days since 2004. As of 11 March 2015 Andrew still owns at least 43,036 units of Cytokinetics Inc stock.

You can see the complete history of Andrew Wolff stock trades at the bottom of the page.



What's Andrew Wolff's mailing address?

Andrew's mailing address filed with the SEC is 280, East Grand Avenue, South San Francisco, San Mateo County, California, 94080, United States.

Insiders trading at Cytokinetics Inc

Over the last 21 years, insiders at Cytokinetics Inc have traded over 50,353,277$ worth of Cytokinetics Inc stock and bought 879,922 units worth 7,454,506$ . The most active insiders traders include Partners L P/Ilbiotechnolog...Capital Ltd Portfolio Servi...Partners L P/Ilbiotechnolog.... On average, Cytokinetics Inc executives and independent directors trade stock every 14 days with the average trade being worth of 1,225,580$. The most recent stock trade was executed by B Lynne Parshall on 9 September 2024, trading 5,000 units of CYTK stock currently worth 108,050$.



What does Cytokinetics Inc do?

cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. as a leader in muscle biology and the mechanics of muscle performance, we're developing small molecule drug candidates specifically engineered to increase muscle function and contractility.



Complete history of Andrew Wolff stock trades at Cytokinetics Inc

インサイダー
取引
取引
合計金額
Andrew A Wolff
SVP Clinical R、D、CMO
オプション行使 137,813$
11 Mar 2015


Cytokinetics Inc executives and stock owners

Cytokinetics Inc executives and other stock owners filed with the SEC include: